pulmonary edema
In conclusion, low-dose simvastatin therapy significantly improves survival and cardiac function and reduces both cardiac hypertrophy and pulmonary edema via an eNOS-dependent mechanism in a murine model of CHF.
In conclusion, low-dose simvastatin therapy significantly improves survival and cardiac function and reduces both cardiac hypertrophy and <span class="disease" id="16844920-9-138-153">pulmonary edema</span> via an <span class="gene" id="16844920-9-161-165">eNOS</span>-dependent mechanism in a murine model of CHF.